Cetera Advisor Networks’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$630K Buy
15,475
+1,157
+8% +$43.4K ﹤0.01% 1775
2023
Q4
$529K Buy
14,318
+3,281
+30% +$124K ﹤0.01% 1830
2023
Q3
$422K Buy
+11,037
New +$452K ﹤0.01% 1898
2023
Q2
Sell
-8,227
Closed -$314K 2648
2023
Q1
$314K Buy
8,227
+964
+13% +$45.2K ﹤0.01% 2026
2022
Q4
$413K Buy
7,263
+1,652
+29% +$84.6K ﹤0.01% 1783
2022
Q3
$222K Buy
5,611
+89
+2% +$3.93K ﹤0.01% 1789
2022
Q2
$243K Buy
+5,522
New +$239K ﹤0.01% 1732
2020
Q3
Sell
-25
Closed -$1K 1975
2020
Q2
$1K Buy
+25
New +$564 ﹤0.01% 3341
2014
Q4
Sell
-11,700
Closed -$107K 844
2014
Q3
$107K Buy
+11,700
New +$111K 0.01% 794

Other funds holding HALO

Cetera Advisor Networks's HALO Position: Q1 2024 in Review

Cetera Advisor Networks increased its Halozyme (HALO) stake by 8.1% in Q1 2024, buying an estimated $43.4K and bringing the position to 15,475 shares worth $630K. The position accounts for ﹤0.01% of the portfolio, ranked #1775.

Cetera Advisor Networks first reported a position in HALO in Q3 2014 and has held it in 9 quarters since. 414 funds tracked by Wall St. Rank hold HALO as of Q1 2024.

  • Cetera Advisor Networks held 15,475 shares of Halozyme worth $630K as of Q1 2024.
  • Cetera Advisor Networks bought 1,157 Halozyme shares in Q1 2024, an estimated $43.4K.
  • Halozyme made up ﹤0.01% of Cetera Advisor Networks's portfolio in Q1 2024, its #1775 holding.
  • Cetera Advisor Networks first reported a position in Halozyme in Q3 2014 and has held it in 9 quarters since.
  • 414 funds tracked by Wall St. Rank held Halozyme as of Q1 2024.

Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.